Emcure Pharmaceuticals Ltd.

₹1396.9

- 7.35 (-0.52%)

04:01 pm - close price

BSE: EMCURE

NSE: EMCURE

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 35.96Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.96Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 22.49Good: 20

✅

Current Ratio

Bad: 1Current: 1.71Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 19.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.00Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 35.96Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.96Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 22.49Good: 20

✅

Current Ratio

Bad: 1Current: 1.71Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 19.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.00Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2024-06
Net Sales	1556.16	1815.14
Expenditure+	1260.55	1478.82
Other Income+	14.98	23.44
Operating Profit	295.61	336.32
Interest	52.07	58.76
Depreciation and Amortization	67.17	93.59
Profit Before Tax	191.34	207.41
Tax+	50.38	54.82
Net Profit	140.97	152.59

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	60564.15	58553.87	59858.11	66582.51	78959.97
Operational Expenses+	48244.43	45254.79	48046.29	54285.28	64271.43
Operating Profit	12319.72	13299.08	11811.82	12297.23	14688.54
Other Income	353.91	634.73	459.05	569.90	727.85
OPM %	20.34	22.71	19.73	18.47	18.60
Depreciation and Amortisation	3233.10	2448.55	2601.18	3124.07	3841.28
Interest	1981.32	1759.78	2136.08	2371.47	1757.84
Profit Before Tax	6573.27	9725.48	7472.15	7272.28	9713.49
Tax	2349.93	2556.99	1815.58	1916.72	2602.90
Net Profit	3921.47	6622.00	5320.19	4981.83	6813.32

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	66591.06	59473.89	65734.05	77093.67	81217.33
Liabilities+	66591.06	59473.89	65734.05	77093.67	81217.33

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	7044.35	7682.07	7468.53	10972.40	8517.05
Cash from Investing Activity	-2518.48	-7887.91	-4676.85	-7125.12	-940.01
Cash from Financing Activity	-1889.04	-1518.51	-1453.97	-1642.06	-8139.57
Net Cash Flow	2636.83	-1724.35	1337.71	2205.22	-562.53
Opening Cash & Cash Equivalents	-6091.08	-3500.42	-3081.72	-1745.29	439.91
Closing Cash & Cash Equivalents	-3500.42	-3081.72	-1745.29	439.91	-143.11

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	MAR'20	MAR'19	MAR'18	MAR'17	AUG'16
Promoters+	77.88	77.91	77.92	77.94	78.08	48.01	48.00	48.00	47.99	47.69
Public+	22.12	22.09	22.08	22.06	21.92	51.99	52.00	52.00	52.01	52.31
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	126169	133549	139671	143449	152914	0	0	0	0	0

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	7044.35	7682.07	7468.53	10972.40	8517.05
Cash from Investing Activity	-2518.48	-7887.91	-4676.85	-7125.12	-940.01
Cash from Financing Activity	-1889.04	-1518.51	-1453.97	-1642.06	-8139.57
Net Cash Flow	2636.83	-1724.35	1337.71	2205.22	-562.53
Opening Cash & Cash Equivalents	-6091.08	-3500.42	-3081.72	-1745.29	439.91
Closing Cash & Cash Equivalents	-3500.42	-3081.72	-1745.29	439.91	-143.11

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Quarterly Results

In Rs. Cr.	2023-06	2024-06
Net Sales	1556.16	1815.14
Expenditure+	1260.55	1478.82
Other Income+	14.98	23.44
Operating Profit	295.61	336.32
Interest	52.07	58.76
Depreciation and Amortization	67.17	93.59
Profit Before Tax	191.34	207.41
Tax+	50.38	54.82
Net Profit	140.97	152.59

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	60564.15	58553.87	59858.11	66582.51	78959.97
Operational Expenses+	48244.43	45254.79	48046.29	54285.28	64271.43
Operating Profit	12319.72	13299.08	11811.82	12297.23	14688.54
Other Income	353.91	634.73	459.05	569.90	727.85
OPM %	20.34	22.71	19.73	18.47	18.60
Depreciation and Amortisation	3233.10	2448.55	2601.18	3124.07	3841.28
Interest	1981.32	1759.78	2136.08	2371.47	1757.84
Profit Before Tax	6573.27	9725.48	7472.15	7272.28	9713.49
Tax	2349.93	2556.99	1815.58	1916.72	2602.90
Net Profit	3921.47	6622.00	5320.19	4981.83	6813.32

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	66591.06	59473.89	65734.05	77093.67	81217.33
Liabilities+	66591.06	59473.89	65734.05	77093.67	81217.33

Ratios

Reported EPS

Bad: 2Current: 35.96Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.96Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 22.49Good: 20

✅

Current Ratio

Bad: 1Current: 1.71Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 19.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.00Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 35.96Good: 5

✅

Adjusted EPS

Bad: 3Current: 35.96Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 22.49Good: 20

✅

Current Ratio

Bad: 1Current: 1.71Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 19.19Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.00Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Shareholder Pattern

In %	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	MAR'20	MAR'19	MAR'18	MAR'17	AUG'16
Promoters+	77.88	77.91	77.92	77.94	78.08	48.01	48.00	48.00	47.99	47.69
Public+	22.12	22.09	22.08	22.06	21.92	51.99	52.00	52.00	52.01	52.31
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	126169	133549	139671	143449	152914	0	0	0	0	0

Emcure Pharmaceuticals Ltd.

₹1396.9

- 7.35 (-0.52%)

04:01 pm - close price

BSE: EMCURE

NSE: EMCURE

Industry: Pharmaceuticals & Drugs

House: Private

Overview